Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
American Journal of Hematology|September 3, 2022
Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphomaJuan Pablo Alderuccio, Isildinha M Reis, Thomas M Habermann, et al.BMC Medical Genomics|February 1, 2014
Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancerDevin C Koestler, Prabhakar Chalise, Mine S Cicek, et al.Human Molecular Genetics|December 22, 2018
Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancerStacey J Winham, Nicholas B Larson, Sebastian M Armasu, et al.Cancer Informatics|February 14, 2018
Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian CancerYanina Natanzon, Madalene Earp, Julie M Cunningham, et al.Leukemia & Lymphoma|October 13, 2020
The association of health behaviors with quality of life in lymphoma survivorsPriyanka A Pophali, Melissa C Larson, Allison C Rosenthal, et al.Journal of Gynecologic Oncology|June 23, 2024
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX modelsManisha Taya, Xiaonan Hou, Jennifer T Veneris, et al.Oncotarget|November 22, 2017
Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility lociNicholas B Larson, Shannon K McDonnell, Zach Fogarty, et al.American Journal of Hematology|March 28, 2019
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomasSean I Tracy, Melissa C Larson, Andrew L Feldman, et al.Leukemia & Lymphoma|June 14, 2021
Body mass index and survival of patients with lymphomaDai Chihara, Melissa C Larson, Dennis P Robinson, et al.Cancer Research|November 23, 2021
Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian CarcinomaArun Kanakkanthara, Xiaonan Hou, Thomas L Ekstrom, et al.Pageof 11